KRAS and colorectal carcinoma: The cumulative mutations in tumor suppressor genes and proto-oncogenes (including KRAS, NRAS, BRAF, and PIK3CA) in RAS–RAF–MAPK and PI3K–PTEN–AKT signaling pathways lead to the development of CRC [30,31].